1998
DOI: 10.1016/s1076-6332(98)80109-8
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of Gd-DOTA-labeled dextran polymer as an intravascular MR contrast agent for myocardial perfusion

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
40
0

Year Published

1999
1999
2014
2014

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 55 publications
(43 citation statements)
references
References 6 publications
3
40
0
Order By: Relevance
“…As shown in a previous study, CMD-A2-GD-DOTA is a high relaxivity contrast agent and the dose required in this study was fivefold less than that needed for Gd-DOTA (19). In the present study, the intravascular properties of the new contrast agent have been demonstrated by output comparison with a standard intravascular indicator.…”
Section: Discussionsupporting
confidence: 67%
“…As shown in a previous study, CMD-A2-GD-DOTA is a high relaxivity contrast agent and the dose required in this study was fivefold less than that needed for Gd-DOTA (19). In the present study, the intravascular properties of the new contrast agent have been demonstrated by output comparison with a standard intravascular indicator.…”
Section: Discussionsupporting
confidence: 67%
“…Using eq 2, k wl can be rewritten in terms of the liposomal molar concentration [l] (4) where f(r) is the fraction of liposomes with radius r, and N A is Avogadro's number. Thus the exchange rate is directly proportional to the membrane permeability and the total membrane surface area.…”
Section: Theorymentioning
confidence: 99%
“…CMD-A2-Gd-DOTA has been shown to be a potential intravascular contrast agent for studying myocardial perfusion with MR imaging (5).…”
mentioning
confidence: 99%